Cerebral palsy is the most common cause of spasticity and movement disorder in children.
Untreated spasticity leads to many complications, and therefore it is necessary to treat …

The current modalities in managing spastic children have some limitations; thus, alternative
therapeutic agents are in need. The purpose of this study is to investigate whether …

Background/Aim. Cerebral palsy (CP) is the most common physical disability in childhood.
Children have problems with motor functions as a result of limbs spasticity, which leads to …

Abstract Background/Aim. Cerebral palsy (CP) is the most common physical disability in
childhood. Children have problems with motor functions as a result of limbs spasticity, which …

Botulinum toxin is an important element in the therapeutic arsenal used in the treatment of
spastic cerebral palsy. Blocking the neuromuscular plate allows spasticity removal in the …

Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults
- preliminary report. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Abstract Botulinum toxin A (BTX-A) is widely used worldwide to overcome the significant
problem in spastic cerebral palsy (CP). In the past three decades, botulinum toxin serotype A …

BACKGROUND For more than 20 years, intramuscular injections of botulinum toxin A have
been an established treatment for spasticity in children with cerebral palsy. We investigated …

Management of children with cerebral palsy (CP) is the focus of considerable resources in
many countries, so that evaluation of the efficacy for new and established treatments is …

Purpose The purpose of this review is to clarify the role of botulinum toxin serotype A (BTX-
A) in the treatment of children with cerebral palsy (CP), with a special focus on the lower …